Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
No Thumbnail Available
Identifiers
Date
2020-01-01
Authors
Morales-Orue, Ignacio
Zafra-Martin, Juan
Garcia, Laura
Chicas-Sett, Rodolfo
Castilla-Martinez, Juan
Auxiliadora Cabezon, Maria
Burgos, Javier
Lloret, Marta
Lara, Pedro C.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Ame publishing company
Metrics
Export
Abstract
Breast cancer (BC) is the principal cause of cancer-related death in women. Metastatic patients are usually treated with a systemic therapy, but clinical results are limited. Oligometastatic subjects can benefit from high-precision radiotherapy techniques to potentially achieve a complete response. Currently, there is limited evidence of stereotactic ablative radiotherapy (SABR) treatments in elderly oligometastatic cancer patients. A review of the medical literature was performed in PubMed database to assess the current role of SABR in the treatment of breast oligometastases in elderly patients. SABR represents a feasible and safe therapeutic approach in oligometastatic elderly BC patients. Further studies are required to establish the optimum patient selection and treatment scheme.
Description
MeSH Terms
DeCS Terms
CIE Terms
Keywords
Stereotactic ablative radiotherapy (SABR), elderly, oligometastatic, radiotherapy, breast, Body radiation-therapy, Quality-of-life, Brain metastases, Combination chemotherapy, International society, Geriatric assessment, Follow-up, Radiosurgery, Oncology, Sbrt